We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$21B
AUM Growth
+$3.99B
Cap. Flow
-$643M
Cap. Flow %
-3.07%
Top 10 Hldgs %
41.48%
Holding
317
New
46
Increased
82
Reduced
113
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Consumer Discretionary 20.16%
3 Financials 14.28%
4 Healthcare 13.93%
5 Communication Services 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDX icon
51
Celldex Therapeutics
CLDX
$2.9B
$92.5M 0.44%
2,720,877
-355,906
-12% -$13.6M
MMYT icon
52
MakeMyTrip
MMYT
$4.75B
$91.8M 0.44%
988,040
+39,602
+4% +$3.73M
LLY icon
53
Eli Lilly
LLY
$1.01T
$86.8M 0.41%
97,935
-1,277
-1% -$1.15M
DASH icon
54
DoorDash
DASH
$87.5B
$86.4M 0.41%
605,318
+514,589
+567% +$62.4M
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$33.5B
$85.3M 0.41%
310,000
+25,000
+9% +$6.51M
FN icon
56
Fabrinet
FN
$14.9B
$82.4M 0.39%
348,625
-24,337
-7% -$5.63M
ORCL icon
57
Oracle
ORCL
$417B
$82.3M 0.39%
483,245
+332,831
+221% +$48.2M
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$132B
$81.4M 0.39%
175,000
BPMC
59
DELISTED
Blueprint Medicines
BPMC
$81.1M 0.39%
877,005
+2,005
+0.2% +$199K
RYTM icon
60
Rhythm Pharmaceuticals
RYTM
$7.21B
$78.6M 0.37%
1,500,000
VRNS icon
61
Varonis Systems
VRNS
$5.18B
$76.3M 0.36%
1,349,728
-123,418
-8% -$6.49M
REGN icon
62
Regeneron Pharmaceuticals
REGN
$80.5B
$75.5M 0.36%
71,795
-61,236
-46% -$68.1M
PDD icon
63
Pinduoduo
PDD
$113B
$71.4M 0.34%
529,895
+28,506
+6% +$3.5M
UNH icon
64
UnitedHealth
UNH
$344B
$71.3M 0.34%
121,923
-7,064
-5% -$4M
RNAM
65
DELISTED
Avidity Biosciences
RNAM
$70.8M 0.34%
1,542,126
+428,025
+38% +$18.6M
HCA icon
66
HCA Healthcare
HCA
$92.4B
$67.2M 0.32%
165,279
+345
+0.2% +$126K
MNDY icon
67
monday.com
MNDY
$4.06B
$66.7M 0.32%
240,045
+171,692
+251% +$42.5M
COHR icon
68
Coherent
COHR
$52.2B
$64.3M 0.31%
+723,238
New +$54M
ARQT icon
69
Arcutis Biotherapeutics
ARQT
$3B
$64M 0.31%
6,884,372
+5,300
+0.1% +$52.3K
AVDL
70
DELISTED
Avadel Pharmaceuticals
AVDL
$63.4M 0.3%
4,834,028
-1,726,387
-26% -$26.3M
MRUS
71
DELISTED
Merus
MRUS
$63.3M 0.3%
1,267,052
GLOB icon
72
Globant
GLOB
$1.63B
$62.6M 0.3%
316,167
+48,452
+18% +$9.36M
CIEN icon
73
Ciena
CIEN
$45.3B
$62.5M 0.3%
+1,015,146
New +$53.5M
PI icon
74
Impinj
PI
$5.4B
$62M 0.3%
+286,189
New +$48.5M
SUPN icon
75
Supernus Pharmaceuticals
SUPN
$2.41B
$60.4M 0.29%
1,937,930
-2,580
-0.1% -$80.5K

Similar funds

Polar Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Polar Capital Holdings held 317 positions worth $21B, up 24% from $17B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Polar Capital Holdings withdrew a net $643M in Q3 2024, closing 28 positions and reducing 113 holdings. Its most notable exit was Applied Materials, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Polar Capital Holdings opened a new position in MACOM Technology Solutions worth $122M.

  • Polar Capital Holdings's largest Q3 2024 buy was MACOM Technology Solutions: 1,096,992 shares worth $122M.
  • Polar Capital Holdings added most to Mercado Libre in Q3 2024, an estimated $110M increase.
  • Polar Capital Holdings's biggest Q3 2024 reduction was CrowdStrike, cutting an estimated $214M.
  • Polar Capital Holdings fully exited Applied Materials in Q3 2024, selling an estimated $140M.
  • Polar Capital Holdings's ten largest holdings make up 41% of its $21B portfolio in Q3 2024.
  • Polar Capital Holdings opened 46 new positions and closed 28 in Q3 2024.
  • Polar Capital Holdings's portfolio value rose 24% quarter-over-quarter to $21B.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.